查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1819868

2025-2033年抗凝血劑市場報告（依藥物類別、給藥途徑、配銷通路、應用及地區）

Anticoagulants Market Report by Drug Class, Route of Administration, Distribution Channel, Application, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球抗凝血劑市場規模達449億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到968億美元，2025-2033年期間的複合年成長率（CAGR）為8.46%。血栓性疾病病例的增加、久坐不動的生活方式以及醫療保健產業的改善是推動市場發展的一些關鍵因素。

抗凝血劑是一種預防血栓形成並降低中風、心臟病等嚴重疾病風險的藥物。它們有助於治療阻礙血液在血管中流動的現有血栓，防止其擴大，並降低嚴重併發症的風險。抗凝血劑有不同強度和顏色，有口服劑型（例如片劑和膠囊）和注射劑型。目前，直介面服抗凝血劑 (DOAc) 因其使用方便且無需常規監測，正日益成為處方藥。

抗凝血劑市場趨勢：

全球範圍內老年人口的成長以及人類免疫缺陷病毒 (HIV)、萊姆病、肥胖症、丙型肝炎、慢性發炎和心血管疾病的日益流行是影響全球市場的關鍵因素之一。此外，由於久坐的生活方式和繁忙的工作日程，肺栓塞 (PE) 等血栓性疾病病例不斷增加，導致全球心臟相關疾病增加。久坐、吸菸、創傷、血液疾病和自體免疫疾病會增加身體不同部位血液凝結的風險，從而刺激對抗凝劑的需求。除此之外，藥物發現研發 (R&D) 活動的不斷進步以及人工智慧 (AI) 和機器學習 (ML) 等先進技術的整合，用於分析大量資料、識別潛在候選藥物和開發新藥，正在推動市場成長。與此相符的是，醫療保健提供者正致力於根據患者的基因和臨床資料，為其提供個人化的抗凝血治療。人工智慧有助於確定最有效的抗凝血劑劑量和類型，從而降低併發症風險並改善治療效果。此外，非營利組織為提高心血管健康意識而採取的積極舉措，以及各國政府與公共衛生機構在預防心臟病和中風方面日益加強的合作，正在推動全球市場的成長。醫療保健行業的蓬勃發展以及藥品價格和可及性的提高等其他因素也刺激了市場的成長。

本報告回答的關鍵問題

  • 2024年全球抗凝血劑市場規模？ 2025-2033年全球抗凝血劑市場的預期成長率是多少？
  • 推動全球抗凝血劑市場發展的關鍵因素有哪些？
  • COVID-19 對全球抗凝血劑市場有何影響？
  • 根據藥物類別，全球抗凝血劑市場是如何分類的？
  • 根據給藥途徑，全球抗凝血劑市場如何分佈？
  • 根據配銷通路，全球抗凝血劑市場如何分佈？
  • 根據應用，全球抗凝血劑市場是如何分佈的？
  • 全球抗凝血劑市場的主要區域有哪些？
  • 全球抗凝血劑市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球抗凝血劑市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依藥品類別

  • 新型口服抗凝血藥物（NOAC）
  • 肝素和低分子量肝素（LMWH）
  • 維生素K拮抗劑
  • 其他

第7章：市場區隔：依行政途徑

  • 口服抗凝血劑
  • 注射用抗凝血劑

第8章：市場區隔：按配銷通路

  • 醫院藥房
  • 零售藥局
  • 網路商店
  • 其他

第9章：市場區隔：依應用

  • 心房顫動和心臟病發作
  • 中風
  • 深部靜脈血栓（DVT）
  • 肺栓塞（PE）
  • 其他

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 11 章：SWOT 分析

第 12 章：價值鏈分析

第 13 章：波特五力分析

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Alexion Pharmaceuticals Inc
    • Aspen Holdings
    • Bayer AG
    • Boehringer Ingelheim International GmbH
    • Bristol-Myers Squibb Company
    • Daiichi Sankyo Company Limited
    • Dr. Reddy's Laboratories Ltd
    • GlaxoSmithKline plc
    • Johnson & Johnson Private Limited
    • Pfizer Inc.
    • Sanofi
Product Code: SR112025A4360

The global anticoagulants market size reached USD 44.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 96.8 Billion by 2033, exhibiting a growth rate (CAGR) of 8.46% during 2025-2033. The rising cases of thrombotic disorders, sedentary lifestyles, and the improving healthcare sector represent some of the key factors driving the market.

Anticoagulants are medicines that prevent the formation of blood clots and reduce the chances of developing severe conditions, such as strokes and heart attacks. They assist in treating existing blood clots that resist the flow of blood through vessels and prevent them from getting larger and reducing the risk of serious complications. They are available in different strengths and colors and as oral, such as tablets and capsules, and injectable variants. At present, direct oral anticoagulants (DOAc) are increasingly being prescribed on account of their ease of use and lack of need for routine monitoring.

Anticoagulants Market Trends:

The growing geriatric population and increasing prevalence of human immunodeficiency virus (HIV), lyme disease, obesity, hepatitis C, chronic inflammation, and cardiovascular disorders across the globe represent one of the key factors positively influencing the market across the globe. In addition, rising cases of thrombotic disorders, such as pulmonary embolism (PE), on account of sedentary lifestyles and hectic work schedules are inducing the growth of heart-related diseases worldwide. Moreover, extended sitting, smoking, trauma, blood disorders, and autoimmune diseases are increasing the risk of blood clotting in different parts of the body, which, in turn, is catalyzing the demand for anticoagulants. Apart from this, increasing advancements in research and development (R&D) activities in drug discovery and the integration of advanced technologies, such as artificial intelligence (AI) and machine learning (ML) to analyze large amounts of data, identify potential drug candidates and develop a new drug is fueling the market growth. In line with this, healthcare providers are focusing on personalizing anticoagulant therapy for individual patients based on their genetic and clinical data. AI assists in identifying the most effective dose and type of anticoagulant for the patient, which, in turn, reduces the risk of complications and improves outcomes. Furthermore, favorable initiatives by non-profitable organizations to promote awareness about cardiovascular health and the growing partnerships between governments of various countries and public health agencies to prevent heart disease and strokes are propelling the growth of the market worldwide. Other factors like the burgeoning healthcare sector and increasing affordability and accessibility of drugs are stimulating the growth of the market.

Key Market Segmentation:

Drug Class Insights:

  • Novel Oral Anticoagulants (NOACs)
  • Heparin and Low Molecular Weight Heparin (LMWH)
  • Vitamin K Antagonist
  • Others

Route of Administration Insights:

  • Oral Anticoagulant
  • Injectable Anticoagulant

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores
  • Others

Application Insights:

  • Atrial Fibrillation and Heart Attack
  • Stroke
  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Others

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for anticoagulants. Some of the factors driving the North America anticoagulants market included the increasing prevalence of thrombotic disorders, developed healthcare sector, ongoing research and development (R&D) activities in drug discovery etc.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global anticoagulants market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Alexion Pharmaceuticals Inc, Aspen Holdings, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Dr. Reddy's Laboratories Ltd, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Pfizer Inc., Sanofi, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report

Key Questions Answered in This Report

  • 1.What was the size of the global anticoagulants market in 2024?
  • 2.What is the expected growth rate of the global anticoagulants market during 2025-2033?
  • 3.What are the key factors driving the global anticoagulants market?
  • 4.What has been the impact of COVID-19 on the global anticoagulants market?
  • 5.What is the breakup of the global anticoagulants market based on the drug class?
  • 6.What is the breakup of the global anticoagulants market based on the route of administration?
  • 7.What is the breakup of the global anticoagulants market based on the distribution channel?
  • 8.What is the breakup of the global anticoagulants market based on the application?
  • 9.What are the key regions in the global anticoagulants market?
  • 10.Who are the key players/companies in the global anticoagulants market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Anticoagulants Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Novel Oral Anticoagulants (NOACs)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Heparin and Low Molecular Weight Heparin (LMWH)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Vitamin K Antagonist
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral Anticoagulant
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Injectable Anticoagulant
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Atrial Fibrillation and Heart Attack
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Stroke
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Deep Vein Thrombosis (DVT)
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Pulmonary Embolism (PE)
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Alexion Pharmaceuticals Inc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Aspen Holdings
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Boehringer Ingelheim International GmbH
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Bristol-Myers Squibb Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Daiichi Sankyo Company Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Dr. Reddy's Laboratories Ltd
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 GlaxoSmithKline plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Johnson & Johnson Private Limited
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Sanofi
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Anticoagulants Market: Major Drivers and Challenges
  • Figure 2: Global: Anticoagulants Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Anticoagulants Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Anticoagulants Market: Breakup by Drug Class (in %), 2024
  • Figure 5: Global: Anticoagulants Market: Breakup by Route of Administration (in %), 2024
  • Figure 6: Global: Anticoagulants Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Anticoagulants Market: Breakup by Application (in %), 2024
  • Figure 8: Global: Anticoagulants Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Anticoagulants (Vitamin K Antagonist) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Anticoagulants (Vitamin K Antagonist) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Anticoagulants (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Anticoagulants (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Anticoagulants (Oral Anticoagulant) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Anticoagulants (Oral Anticoagulant) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Anticoagulants (Injectable Anticoagulant) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Anticoagulants (Injectable Anticoagulant) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Anticoagulants (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Anticoagulants (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Anticoagulants (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Anticoagulants (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Anticoagulants (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Anticoagulants (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Anticoagulants (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Anticoagulants (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Anticoagulants (Stroke) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Anticoagulants (Stroke) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Anticoagulants (Pulmonary Embolism-PE) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Anticoagulants (Pulmonary Embolism-PE) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Anticoagulants (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Anticoagulants (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: North America: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: North America: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: United States: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: United States: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Canada: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Canada: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Asia-Pacific: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Asia-Pacific: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: China: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: China: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Japan: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Japan: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: India: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: India: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: South Korea: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: South Korea: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Australia: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Australia: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Indonesia: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Indonesia: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Europe: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Europe: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Germany: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Germany: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: France: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: France: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: United Kingdom: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: United Kingdom: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Italy: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Italy: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Spain: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Spain: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Russia: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Russia: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Others: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Others: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Latin America: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Latin America: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Brazil: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Brazil: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Mexico: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Mexico: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Others: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Others: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Middle East and Africa: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Middle East and Africa: Anticoagulants Market: Breakup by Country (in %), 2024
  • Figure 87: Middle East and Africa: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Global: Anticoagulants Industry: SWOT Analysis
  • Figure 89: Global: Anticoagulants Industry: Value Chain Analysis
  • Figure 90: Global: Anticoagulants Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Anticoagulants Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Anticoagulants Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
  • Table 3: Global: Anticoagulants Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 4: Global: Anticoagulants Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Anticoagulants Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 6: Global: Anticoagulants Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Anticoagulants Market: Competitive Structure
  • Table 8: Global: Anticoagulants Market: Key Players